Literature DB >> 8487323

Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer.

S J London1, F M Sacks, M J Stampfer, I C Henderson, M Maclure, A Tomita, W C Wood, S Remine, N J Robert, J R Dmochowski.   

Abstract

BACKGROUND: Studies in animals and geographic correlations across populations suggest that fatty acid intake may have a positive relationship with breast cancer risk, but analytic epidemiologic studies of fat intake have been less supportive. Adipose tissue analysis provides a more objective assessment of intakes of fatty acids that are not endogenously synthesized than do the questionnaire survey methods used in many epidemiologic studies.
PURPOSE: This case-control study of postmenopausal women was designed to examine the relationship between fatty acid composition of subcutaneous adipose tissue and risk of breast cancer and proliferative benign breast disease. In addition, we examined specific hypotheses that breast cancer risk is negatively associated with long-chain N-3 fatty acid intake, positively associated with trans fatty acid intake, and positively associated with increased intake of polyunsaturated fat together with low intake of antioxidants.
METHODS: Aspirates of subcutaneous fat from the buttocks were obtained from 380 women with newly diagnosed stage I or II breast cancer and 176 with proliferative benign breast disease. A total of 397 women who were evaluated for breast abnormalities at the same institutions but did not require breast biopsy or whose biopsy revealed nonproliferative benign breast disease served as the control group. We examined associations between saturated, monounsaturated, polyunsaturated, trans, or long-chain N-3 fatty acids and breast cancer, atypical hyperplasia, or proliferative benign breast disease without atypia.
RESULTS: We observed no consistent patterns of association between breast cancer risk and any of the categories of fatty acids or the individual constituent fatty acids in the adipose tissue. Saturated fatty acids were inversely associated with risk of proliferative benign breast disease without atypia but not with atypical hyperplasia or breast cancer. This association was not observed, however, when total fat intake was taken into account. Women with high levels of polyunsaturated fatty acids in adipose tissue and low serum or dietary levels of antioxidants were not observed to be at higher risk of breast cancer.
CONCLUSIONS: Using an objective measure of intake, we observed no major associations between polyunsaturated fatty acids, including long-chain N-3 fatty acids and trans fatty acids, and risk of breast cancer or proliferative benign breast disease. IMPLICATIONS: These data do not support the hypothesis that intake of specific fatty acids, particularly polyunsaturated and trans fatty acids, is an important risk factor for malignant or benign breast disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487323     DOI: 10.1093/jnci/85.10.785

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

1.  Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Authors:  Lisa D Yee; Joanne L Lester; Rachel M Cole; Julia R Richardson; Jason C Hsu; Yan Li; Amy Lehman; Martha A Belury; Steven K Clinton
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

2.  In vivo determination of human breast fat composition by ¹H magnetic resonance spectroscopy at 7 T.

Authors:  Ivan E Dimitrov; Deborah Douglas; Jimin Ren; Nadine B Smith; Andrew G Webb; A Dean Sherry; Craig R Malloy
Journal:  Magn Reson Med       Date:  2011-06-07       Impact factor: 4.668

3.  Nutrition and cancer: a review of the evidence for an anti-cancer diet.

Authors:  Michael S Donaldson
Journal:  Nutr J       Date:  2004-10-20       Impact factor: 3.271

4.  Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China.

Authors:  Jackilen Shannon; Irena B King; Johanna W Lampe; Dao Li Gao; Roberta M Ray; Ming-Gang Lin; Helge Stalsberg; David B Thomas
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

5.  Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial.

Authors:  Thomas E Rohan; Abdissa Negassa; Bette Caan; Rowan T Chlebowski; J David Curb; Mindy Ginsberg; Dorothy S Lane; Marian L Neuhouser; James M Shikany; Sylvia Wassertheil-Smoller; David L Page
Journal:  Cancer Prev Res (Phila)       Date:  2008-07-09

Review 6.  Essential fatty acid consumption and risk of breast cancer.

Authors:  P A Godley
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 7.  Increase in adipose tissue linoleic acid of US adults in the last half century.

Authors:  Stephan J Guyenet; Susan E Carlson
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

8.  Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study.

Authors:  Véronique Chajès; Anne C M Thiébaut; Maxime Rotival; Estelle Gauthier; Virginie Maillard; Marie-Christine Boutron-Ruault; Virginie Joulin; Gilbert M Lenoir; Françoise Clavel-Chapelon
Journal:  Am J Epidemiol       Date:  2008-04-04       Impact factor: 4.897

9.  Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.

Authors:  Yumie Takata; Irena B King; Marian L Neuhouser; Steve Schaffer; Matt Barnett; Mark Thornquist; Ulrike Peters; Gary E Goodman
Journal:  Cancer Causes Control       Date:  2009-03-03       Impact factor: 2.506

10.  Baseline patterns of adipose tissue fatty acids and long-term risk of breast cancer: a case-cohort study in the Danish cohort Diet, Cancer and Health.

Authors:  J A Schmidt; A Gorst-Rasmussen; P W Nyström; J H Christensen; E B Schmidt; C Dethlefsen; A Tjønneland; K Overvad; C C Dahm
Journal:  Eur J Clin Nutr       Date:  2014-03-19       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.